Madden Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Madden Securities's GILD Position: Q2 2025 in Review
Madden Securities sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 9,155 shares — an estimated $1.03M sold.
Madden Securities first reported a position in GILD in Q4 2020 and held it in 17 quarters. The position peaked at $1.83M in Q3 2024. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.
- Madden Securities reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
- Madden Securities sold 9,155 Gilead Sciences shares in Q2 2025, an estimated $1.03M.
- Madden Securities first reported a position in Gilead Sciences in Q4 2020 and held it in 17 quarters.
- Madden Securities's Gilead Sciences position peaked at $1.83M in Q3 2024.
- 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.
Based on Madden Securities's 13F filing for Q2 2025, filed 23 Jul 2025.